Multiple Sclerosis (MS) is a chronic, incurable neurological disease which affects more than 2.5 million people worldwide (1) . Fatigue is reported by around 90% of people affected by MS (PaMS) with over two-thirds complaining it is their most troubling symptom (2) . Fatigue is a major reason for unemployment in MS (3) and is associated with depression and inability to carry out day-to-day tasks (4;5).
Few treatments have been shown to be effective for MS fatigue. Evidence from pharmacotherapy trials is inconsistent and effects are modest at best (4;6). Other studies have used a more behavioural approach using either exercise or energy conservation methods but again results are mixed (3) . These interventions are limited by the absence of a clear conceptualisation of MS fatigue. We recently developed a cognitive-behavioural conceptualisation of MS fatigue integrating the findings across biological and psychosocial research (6) . Based on this model, we developed a cognitive behavioural therapy (CBT) programme which was shown in a randomised controlled trial (RCT) to effectively reduce fatigue up to six month follow-up (7).
Despite these promising results, rolling out individual CBT for MS fatigue is likely to be problematic. Few MS services have access to a CBT therapist and attending therapy sessions may be difficult for many PaMS. The provision of CBT-based self-management programmes over the Internet is a rapidly evolving and potentially beneficial means of delivering treatment otherwise unsought or unobtainable (8) . There is growing evidence that Internetbased interventions are an effective form of treatment for a variety of physical symptoms, including back pain, headache and tinnitus (9) (10) (11) particularly when supplemented by some telephone support (12) .
The initial aim of the current study was to develop an Internet self-management package for MS fatigue (MS Invigor8) based on our therapist-delivered CBT programme and formalised feedback from (PaMS). The second aim was to conduct a pilot RCT of MS Invigor8. The aims of the pilot were to 1) assess the feasibility of conducting automated trial randomisation and baseline and follow-up assessment procedures online, 2) evaluate adherence to the treatment programme, 3) assess the potential efficacy of the programme in reducing fatigue severity and impact (primary outcomes), and depressed and anxious mood (secondary outcomes) at 10 weeks post randomisation, 4) conduct a preliminary cost-effective analysis of the programme, and 5) gather detailed qualitative feedback on the programme from participants to make revisions if necessary before we consider a full sized RCT.
Method Phase 1: Developing MS Invigor8: Breaking the Cycle of Fatigue
Agile design (13) was used to develop MS Invigor8. Agile design incorporates a co-design team who work closely together to produce software, whilst maintaining constant links with the end user. The design team included a software project manager (GW), software developers, health psychologists (RM, LY) and an expert paMS. The website was designed in a modular, iterative fashion. Six volunteers with MS fatigue (two men, four women, mean age 45, with different types and severity of MS, and differing computer skills) assisted the co-design team. They tested the modules in their own homes as they were developed.
Immediately after completing each module, they were interviewed on the telephone using a variant of the 'think aloud' method (14) which is used to understand the different perspectives of individual users. Feedback was elicited about their experience of the module, focusing on issues of usability, usefulness and acceptability of the information, and suggestions for improvements. Interviews were recorded, transcribed verbatim, and analysed.
The feedback was used to modify session content and programme functionality. The programme is summarised in table 1 and described under treatment below.
Phase 2: Pilot Study
Design and trial procedures.
The pilot RCT study was approved by the University of Southampton ethics committee. The website was designed to incorporate all trial and treatment procedures. Participant information sheets including eligibility criteria were presented online with the facility to contact the investigators for more information. PaMS who wanted to participate consented online and completed an online screening questionnaire to confirm eligibility. Those who were eligible could then consent to enter the trial and complete the baseline questionnaire.
They were allocated to MSInvigor8 or a control group by an automated simple randomisation system built into the website. Participants were alerted to complete the online follow-up questionnaire at 10 weeks post randomisation. Control participants were given access to MSInvigor8 once they had completed the 10 week questionnaire, but they did not receive the telephone support.
Recruitment and eligibility
Recruitment was through advertisements on the MS Society and MS Trust websites and a local press release. Participants were required to be UK Resident, have a definite diagnosis of MS from a neurologist, have significant fatigue indicated by a score >4 on the Fatigue scale using the binary scoring method (15) , and be ambulatory with or without a stick for at least 100 meters. Participants had to be willing to abstain from starting new treatments for fatigue for the study duration.
The recruitment target was to randomise 40 participants within the two month recruitment period. A pilot Phase II trial of at least 30 subjects is considered adequate for obtaining reasonably reliable sample size estimates (16) . A slightly larger sample size allowed us to account for possible loss to follow-up to estimate sample size for a full Phase III trial as well as to assess trial methodologies and procedures across a range of people.
112 people underwent the automated screening process. 74 of the 112 screened did not register for the trial. Reasons for non-registration are outlined in Figure 1 .
48 of the 112 people screened registered for the trial of whom 8 had to be withdrawn. 3 people were excluded as they were subsequently found to be non-UK resident. Five participants who registered and were randomised to the control group were withdrawn because a website bug allowed them to access sessions on MSInvigor8 during the control period. Twenty-three people were randomly allocated to the MSInvigor8 group and 17 to the control group. Recruitment took a total of 61 days. 
Assessments
Participants provided demographic data, and information on their MS type and duration.
Questions to quantify MS type were drawn from previous research (17) . Ambulation ability was measured using the ambulation questions from the self-report Expanded Disability Status Scale (18) .
The primary outcomes were: 1) Fatigue severity, measured by the ordinal version of the Fatigue Scale (15) . This questionnaire measures physical and mental fatigue severity, was used in the CBT therapist trial for MS fatigue (7) Fifteen of the 23 MS Invigor8 participants agreed to be interviewed about their experiences of the intervention. A health psychology researcher independent of the trial team conducted semi-structured interviews based around experiences of fatigue, treatment expectations and how the participant was feeling following the intervention. Participants were also asked about experiences of using MS Invigor8 and the telephone support and specific elements they had found helpful and unhelpful. Data-driven thematic analysis was used to identify common and salient themes (24;25) .
Statistical analysis
Analyses were performed using SPSS for Windows (Version 17; SPSS Inc, Chicago, IL). As this is the pilot study, data were presented descriptively. We also conducted treatment effect analyses by intention-to-treat; for participants that dropped out, baseline scores were carried forward to post-treatment. The exception to this was the five control participants who had erroneously accessed MSInvigor8. They only provided baseline data and were removed entirely from all analyses as they were deemed to no longer be true controls. As they did not provide follow-up data, their inclusion would have seriously biased the results in favour of the treatment group. Differences between groups were analysed using general linear models with group as the fixed factor, baseline values as covariates and post treatment scores as the dependent variable.
Economic analysis
Service costs were calculated by combining the service use data with appropriate unit costs (26) . QALYs were calculated by adding the baseline and follow-up EQ-5D scores and dividing by 2, assuming a linear (change over time) and multiplying by 10/52 (which is the maximum QALY gain attainable in the follow-up period). Table 2 shows characteristics of the participants. The mean age was early forties, most participants were female, and 30% were unemployed or working less because of their MS.
Results

Participants
The groups were well matched for age and time since diagnosis. However, the intervention group had a slightly lower percentage of females, a greater percentage of people with progressive disease, and greater levels of ambulatory difficulties than the control group.
Three of the 23 treatment participants failed to complete follow-up assessments. They were the lowest users of the site, with one not completing any sessions. One of the controls did not complete follow-up assessment but no reason was given.
Adherence to intervention
At the 10 week assessment point the mean number of sessions completed was 4.91 (SD 2.10).
Only one (4.3%) participant finished all 8 sessions and three (13%) finished 7 sessions. 
Descriptive outcome data
The means and standard deviations for the outcome data across groups are presented in table 3. The groups appear well matched on baseline levels of fatigue and mood. The control group appears to show little change over the 10 weeks in all four outcomes, whilst the treatment group shows decreases on both fatigue measures as well as anxiety and depression.
Analysis of Primary outcomes
The MS Invigor8 group showed significant reductions when compared to the control group on both the Fatigue Scale (F(2,37) 
Analysis of Secondary outcomes
There were significant differences between the groups on anxiety (F(2,36= 12.31, p=.001) and depression (F(2,36)= 13.33, p=.001), with the MS Invigor8 group showing significantly greater reductions on both scales.
We re-ran the outcome analysis controlling for gender and ambulation status and a completer only analysis (those who returned follow-up), and the results retained their significance levels for all outcomes.
Cost-effectiveness
During the follow-up period the most commonly used services were neurologists and general practitioners (Table 4 ). Mean costs were very similar in the intervention (£211) and control (£214) groups. There is therefore no evidence that during the treatment period the intervention had any impact on the use and cost of other services. Medication costs were not included, although it is unlikely these would differ between groups. Two participants in the control group did start to receive a disease modifying agent during the follow-up period but it is difficult to assess whether this would be due to lack of the intervention.
The mean (SD) EQ-5D scores at baseline were 0.56 (0.26) in the intervention group and 0.64 (0.28) in the control group. By follow-up the scores were 0.71 (0.28) in the intervention group and 0.62 (0.27) in the control group. The mean score at follow-up, adjusted for baseline, was 0.15 higher for the intervention group (p=0.038). The mean (SD) QALY gain for the intervention group was 0.1212 and 0.1243 in the control group. However, due to the quality of life difference at baseline the QALY gain was 0.015 higher in the intervention group (p=0.038).
Qualitative feedback from people in the treatment group.
The interviews (n=15) revealed that most participants perceived an improvement in their fatigue, felt they understood their fatigue better, were more in control of it and were trying to implement lifestyle changes suggested by the programme. The structure of the programme was generally well accepted but occasional technical difficulties with the programme were detrimental to many users' experiences, especially those using certain Internet browsers. Participants also offered suggestions for modifications to website layout and operation. Further customisation was seen as necessary by some, including a few people with progressive forms of MS suggesting that the programme may be more relevant to those with relapsing-remitting MS.
Discussion
This study developed a novel Internet based intervention, MS Invigor8, which has the potential to make CBT based self-management for fatigue more widely available to PaMS.
Strengths of the programme included its iterative development process with input from PaMS and its basis on a theoretical and evidenced-based approach for treating MS fatigue (6;7).
The pilot data suggest that MSInvigor8 has the potential to effectively reduce both severity of fatigue and its impact on daily living. The between group effect sizes for the fatigue measures at the end of treatment were well above the 0.80 cut-off for a large treatment effect (27) . MS Invigor8 also had a significant positive effect on both anxiety and depression.
These data add to a growing body of literature showing that Internet-delivered self-help CBT with minimal therapist support is an effective treatment option for a range of symptom based problems such as tinnitus, headache, chronic pain, insomnia and irritable bowel syndrome (28;29) .
In terms of economics, we measured other service costs rather than direct cost of the intervention because the latter would depend on how many people in routine practice made use of it. Service costs were very similar between the groups over the 10 week period.
However, this period may be too short to show much change in service use costs. The intervention produced more QALYs. To achieve a cost per QALY of £20,000 (below which interventions in England are usually recommended) the intervention costs would need to be no more than £300 per person (£20000 divided by 0.015 QALYs), or approximately £50 per session. If the intervention were never used beyond the 23 in the intervention group then this would only cover £6900 development costs. However, if the intervention is effective it is likely to be used by many more. If 300 people used it then this would cover a £90,000 development cost which is above the actual costs that were accrued. More widespread use would clearly offset these costs to greater extent, as would maintaining the QALY gain beyond 10 weeks.
Internet delivery of the intervention appeared to be acceptable to most participants. PaMS self-referred into this study. Recruitment targets were met quickly suggesting that PaMS are self motivated to receive such treatments. There were also few drop outs. In depth interview feedback was largely positive, with many participants finding MS Invigor8 more helpful than other treatments they had tried. The telephone support was also seen by most as a key component of the treatment. Negative feedback centered on problems with website bugs rather than the nature of the treatment. Additional feedback was given to improve on minor aspects of the intervention structure and content. These revisions and bug fixing will improve the programme for future users.
The adherence data suggests that patients struggled to complete the programme within ten weeks. Interestingly a number of people continued with the website treatment after the study was finished. Thus, a longer treatment period may be required, possibly with more structured support by email or telephone to assist with progress.
In the original therapist trial of CBT for MS fatigue, all PaMS in the CBT group completed the 8 sessions (7). The average change on the Fatigue Scale in the original trial was 13.04 points compared to 9 points in the current study. The eligibility criteria for both trials were the same and the baseline fatigue scores were similar. It would therefore be interesting to investigate the relative clinical and cost-effectiveness of these two approaches in a future trial.
Further research comparing different doses of therapist time alongside the website would help ascertain optimal contact time. Therapist skill may also influence treatment effects; therapy support in this study was provided by a psychology assistant with minimal CBT experience, whereas the therapy trial included an experienced clinical psychologist This study suffered certain limitations linked to the Internet technology. The development of the website proved extremely time-consuming. This part of the project overran leaving insufficient time to adequately test the website before we went to trial. This meant that many participants encountered bugs in the programme. Most could work around these, but the qualitative data suggested that the problems negatively affected participants' treatment experiences. Problems also occurred with using the website for trial procedures such as screening and self-entry into the trial. It had been hoped that incorporating these into the website would be a feasible means of reducing trial research costs and widening the recruitment base. However, our experiences suggest that handling these trial procedures independently will provide better control over recruitment and eligibility.
The current study was a small pilot/feasibility trial of volunteers recruited over the internet and there was no long term follow-up data. A larger more definitive RCT is now needed with longer term follow up to examine maintenance of treatment gains.
Conclusion
Internet CBT based self-management appears to be a promising, acceptable and cost-effective approach for treating MS fatigue and improving broader outcomes such as distress. If future research replicates these findings MSInvigor8 may be a feasible means of delivering a CBTbased intervention to a large pool of PaMS who experience troubling and disabling fatigue. 1 An initial website fault meant that 5 participants allocated to the waiting list control were able to access the web site. These people were withdrawn from the trial 2 Baseline data missing for one control on three of the outcome measures. For these analyses only 16 controls are included but the primary data is analysed for 17
Registered
(n=48)
Did not register (n=74)  Not meeting inclusion criteria (n=17)  Did not consent to trial/data collection (n=35)  Unknown (n=22) Introduction to self-management based on CBT principles including the role of homework.
Withdrawn
Interactive tasks include the steps of keeping daily diaries of activity, rest and fatigue levels. Interactive task to generate possible alterative attributions for somatic symptoms e.g. stress, medication side effects.
Homework: Recording somatic symptoms and generating alternative attributions.
6
Title: Recording Thoughts
The concept of unhelpful thoughts is introduced, and how these impact on fatigue and mood.
Interactive tasks include identifying cognitive errors and generating alternate thoughts.
Homework: Daily thought records of unhelpful thoughts and possible alternatives.
7
Title: Managing Stress
Basic stress management is discussed. Interactive tasks include identifying stressors which are controllable and those which are not, and matching these to appropriate stress management strategies.
Homework: Goals for stress management 8
Title: Emotions, Support and the Future
The importance of social support is discussed, and how to access better social support. Interactive tasks include identifying possible sources of support for different types of support needed.
Managing difficult emotions and relapse are reviewed.
Homework: Building tool set for long term fatigue management and possible relapse. 
